Health food for preventing and treating cardiac and cerebral thrombotic diseases

Abstract

The invention provides a health food for preventing and treating cardiac and cerebral thrombotic diseases and relates to the field of health foods. The health food is prepared from 2-4 parts by weight of garlics, 2-4 parts by weight of yolks, 3-4 parts by weight of poria cocos, 1-3 parts by weight of ginseng, 3-4 parts by weight of ganoderma lucidum, 90-100 parts by weight of natto, 3-4 parts by weight of pseudo-ginseng and 2-3 parts by weight of Chinese yam. The health food has effects of softening and dredging blood vessels, reducing blood fat and blood pressure, improving a cell regeneration capability and preventing and treating arteriosclerosis, contains components such as soybean polypeptide and phosphatidylcholine bilayer with functions of reducing cholesterol, softening blood vessels and preventing and treating blood vessel hardening, contains streptokinase with functions of dissolving thrombus and fat embolus and reducing blood fat and has functions of preventing and treating hypertension, myocardial infarction and cerebral hemorrhage.

Description

technical field

[0001] The invention relates to the field of health food, in particular to a health food for preventing and treating cardiovascular and cerebrovascular diseases. Background technique

[0002] Cardiovascular and cerebrovascular diseases are collectively referred to as diseases of the heart and cerebrovascular diseases. It is also known as the "three highs" of "rich man's disease". 40% to 45% of the elderly over the age of 60 suffer from high blood pressure and high blood fat. According to the statistics of the Ministry of Health in 2007, according to foreign data, about 50% of diabetics have combined A variety of geriatric diseases such as hypertension and hyperlipidemia. Cardiovascular and cerebrovascular diseases have the characteristics of "high morbidity, high disability rate, high mortality, high recurrence rate, and many complications", that is, "four highs and one high". At present, there are more than 270 million patients with cardiovascular and cere...